European Approval for Lung and Skin Cancer Drugs European Approval for Lung and Skin Cancer Drugs
The European Medicines Agency granted marketing authorization for tislelizumab and retifanlimab for the treatment of non –small cell lung cancer and Merkel cell carcinoma, respectively.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Hematology-Oncology Source Type: news

EMA Approves Tx for Psoriasis and Other Autoimmune Disorders EMA Approves Tx for Psoriasis and Other Autoimmune Disorders
The biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Dermatology Source Type: news

' Superclinic' Powers Through Skin Cancer Referrals'Superclinic' Powers Through Skin Cancer Referrals
One hospital ' s experience with this model shows the efficiency of using a dedicated team (including trainees) and offering same-day biopsies and surgery.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Longer IV Ertapenem Course Beneficial for Recalcitrant HS Longer IV Ertapenem Course Beneficial for Recalcitrant HS
2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Dermatology Source Type: news

One-a-Day Pill for Alopecia Recommended for NHS Use One-a-Day Pill for Alopecia Recommended for NHS Use
NICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 22, 2024 Category: Dermatology Tags: Dermatology Source Type: news

FDA Approves First Cellular Therapy for Metastatic Melanoma FDA Approves First Cellular Therapy for Metastatic Melanoma
Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 16, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Cellulite: Outcomes 1 Year After Noninvasive Treatment Cellulite: Outcomes 1 Year After Noninvasive Treatment
The findings build on results from a 12-week study of the device, which the investigators said " induces physical shearing of fibrous septa through rapid acoustic pulses. "MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 16, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Inflammatory Arthritis Has Big Impact on Systemic Sclerosis Inflammatory Arthritis Has Big Impact on Systemic Sclerosis
In patients with SSc, the presence of inflammatory arthritis is significantly associated with diffuse disease, musculoskeletal manifestations, myositis, and sicca.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 15, 2024 Category: Dermatology Tags: Rheumatology Source Type: news

Sweetened Drinks Spell Hormone Trouble for Women Sweetened Drinks Spell Hormone Trouble for Women
Fructose intake from sugar-sweetened beverages increased risk for hyperandrogenism, but fructose intake from fruit did not.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 9, 2024 Category: Dermatology Tags: Diabetes & Endocrinology Source Type: news

Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million
The most expensive gene therapy on the US market may give payers pause, said study authors.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 8, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Comorbidities Weigh Heavily in Autoimmune Pregnancy Outcomes Comorbidities Weigh Heavily in Autoimmune Pregnancy Outcomes
After controlling for other chronic conditions, certain immune-mediated inflammatory diseases were not associated with an increased risk for poor pregnancy outcomes.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 7, 2024 Category: Dermatology Tags: Rheumatology Source Type: news

AAD Updates Acne Management Guidelines AAD Updates Acne Management Guidelines
The new guidelines updated the AAD ' s 2016 guidelines and included 18 recommendations and five good practice statements.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 7, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Pregnancies With Isotretinoin Exposure Rise Sharply Pregnancies With Isotretinoin Exposure Rise Sharply
The absolute annual number was low but doubled over a 15-year period, despite a longstanding prevention program.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 30, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Pitfalls When Your Patient Turns to Telehealth-Only Medicine Pitfalls When Your Patient Turns to Telehealth-Only Medicine
Online visits fulfill a need for timely appointments but can lead to unneeded prescriptions and missed diagnoses, physicians say.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 26, 2024 Category: Dermatology Tags: Family Medicine/Primary Care Source Type: news

How Does Rituximab for Pemphigus Fare in the Long Term? How Does Rituximab for Pemphigus Fare in the Long Term?
This marks the first long-term follow-up data from patients in the Ritux 3 trial who received rituximab as a first-line agent.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 24, 2024 Category: Dermatology Tags: Dermatology Source Type: news